These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 18519730)

  • 1. Effect of chemotherapy with praziquantel on the production of cytokines and morbidity associated with schistosomiasis mansoni.
    Martins-Leite P; Gazzinelli G; Alves-Oliveira LF; Gazzinelli A; Malaquias LC; Correa-Oliveira R; Teixeira-Carvalho A; Silveira AM
    Antimicrob Agents Chemother; 2008 Aug; 52(8):2780-6. PubMed ID: 18519730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrated analysis of innate, Th1, Th2, Th17, and regulatory cytokines identifies changes in immune polarisation following treatment of human schistosomiasis.
    Bourke CD; Nausch N; Rujeni N; Appleby LJ; Mitchell KM; Midzi N; Mduluza T; Mutapi F
    J Infect Dis; 2013 Jul; 208(1):159-69. PubMed ID: 23045617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokine production associated with periportal fibrosis during chronic schistosomiasis mansoni in humans.
    Alves Oliveira LF; Moreno EC; Gazzinelli G; Martins-Filho OA; Silveira AM; Gazzinelli A; Malaquias LC; LoVerde P; Leite PM; Correa-Oliveira R
    Infect Immun; 2006 Feb; 74(2):1215-21. PubMed ID: 16428771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokine profile associated with human chronic schistosomiasis mansoni.
    Magalhães A; Miranda DG; Miranda RG; Araújo MI; Jesus AA; Silva A; Santana LB; Pearce E; Carvalho EM; Jesus AR
    Mem Inst Oswaldo Cruz; 2004; 99(5 Suppl 1):21-6. PubMed ID: 15486630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HTLV-1 modifies the clinical and immunological response to schistosomiasis.
    Porto AF; Santos SB; Alcantara L; Guerreiro JB; Passos J; Gonzalez T; Neva F; Gonzalez D; Ho JL; Carvalho EM
    Clin Exp Immunol; 2004 Aug; 137(2):424-9. PubMed ID: 15270862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Similar cellular responses after treatment with either praziquantel or oxamniquine in Schistosoma mansoni infection.
    Mduluza T; Mutapi F; Ruwona T; Kaluka D; Midzi N; Ndhlovu PD
    Malawi Med J; 2009 Dec; 21(4):176-82. PubMed ID: 21174933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contrasting cellular responses in Schistosoma haematobium infected and exposed individuals from areas of high and low transmission in Zimbabwe.
    Mduluza T; Ndhlovu PD; Midzi N; Scott JT; Mutapi F; Mary C; Couissinier-Paris P; Turner CM; Chandiwana SK; Woolhouse ME; Dessein AJ; Hagan P
    Immunol Lett; 2003 Sep; 88(3):249-56. PubMed ID: 12941484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD4+ T cells of schistosomiasis naturally resistant individuals living in an endemic area produce interferon-gamma and tumour necrosis factor-alpha in response to the recombinant 14KDA Schistosoma mansoni fatty acid-binding protein.
    Brito CF; Caldas IR; Coura Filho P; Correa-Oliveira R; Oliveira SC
    Scand J Immunol; 2000 Jun; 51(6):595-601. PubMed ID: 10849370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of IL-9, IL-10, and IL-17 Cytokines With Hepatic Fibrosis in Human
    Franco KGS; de Amorim FJR; Santos MA; Rollemberg CVV; de Oliveira FA; França AVC; Santos CNO; Magalhães LS; Cazzaniga RA; de Lima FS; Benevides L; Carregaro V; Silva JS; Brito HLF; Fernandes DA; da Silva ÂM; de Almeida RP; Bezerra-Santos M; de Jesus AR
    Front Immunol; 2021; 12():779534. PubMed ID: 34970264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of type 2 cytokines with hepatic fibrosis in human Schistosoma mansoni infection.
    de Jesus AR; Magalhães A; Miranda DG; Miranda RG; Araújo MI; de Jesus AA; Silva A; Santana LB; Pearce E; Carvalho EM
    Infect Immun; 2004 Jun; 72(6):3391-7. PubMed ID: 15155645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human schistosomiasis mansoni: immune responses during acute and chronic phases of the infection.
    Caldas IR; Campi-Azevedo AC; Oliveira LF; Silveira AM; Oliveira RC; Gazzinelli G
    Acta Trop; 2008; 108(2-3):109-17. PubMed ID: 18577364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eosinophil activity in Schistosoma mansoni infections in vivo and in vitro in relation to plasma cytokine profile pre- and posttreatment with praziquantel.
    Reimert CM; Fitzsimmons CM; Joseph S; Mwatha JK; Jones FM; Kimani G; Hoffmann KF; Booth M; Kabatereine NB; Dunne DW; Vennervald BJ
    Clin Vaccine Immunol; 2006 May; 13(5):584-93. PubMed ID: 16682480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of matrix metalloproteinases and their inhibitors during the resorption of schistosome egg-induced fibrosis in praziquantel-treated mice.
    Singh KP; Gerard HC; Hudson AP; Boros DL
    Immunology; 2004 Mar; 111(3):343-52. PubMed ID: 15009436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of praziquantel treatment during pregnancy on cytokine responses to schistosome antigens: results of a randomized, placebo-controlled trial.
    Tweyongyere R; Mawa PA; Ngom-Wegi S; Ndibazza J; Duong T; Vennervald BJ; Dunne DW; Katunguka-Rwakishaya E; Elliott AM
    J Infect Dis; 2008 Dec; 198(12):1870-9. PubMed ID: 18983246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunomodulatory effect of R848 on cytokine production associated with Schistosoma mansoni infection.
    Boghdadi G; Khalik DA; Wahab SA; Farghaly A
    Parasitol Res; 2013 Jan; 112(1):135-40. PubMed ID: 22992895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intestinal schistosomiasis of Ijinga Island, north-western Tanzania: prevalence, intensity of infection, hepatosplenic morbidities and their associated factors.
    Mueller A; Fuss A; Ziegler U; Kaatano GM; Mazigo HD
    BMC Infect Dis; 2019 Oct; 19(1):832. PubMed ID: 31590657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repeated exposure induces periportal fibrosis in Schistosoma mansoni-infected baboons: role of TGF-beta and IL-4.
    Farah IO; Mola PW; Kariuki TM; Nyindo M; Blanton RE; King CL
    J Immunol; 2000 May; 164(10):5337-43. PubMed ID: 10799896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-inflammatory, antioxidant, anti-fibrotic and schistosomicidal properties of plumbagin in murine schistosomiasis.
    Bakery HH; Allam GA; Abuelsaad ASA; Abdel-Latif M; Elkenawy AE; Khalil RG
    Parasite Immunol; 2022 Nov; 44(11):e12945. PubMed ID: 36066812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different cytokine patterns in patients coinfected with hepatitis C virus and Schistosoma mansoni.
    el-Kady IM; el-Masry SA; Badra G; Halafawy KA
    Egypt J Immunol; 2004; 11(1):23-9. PubMed ID: 15724383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of four rounds of annual school-wide mass praziquantel treatment for schistosoma mansoni control on schistosome-specific immune responses.
    Ndombi EM; Abudho B; Kittur N; Carter JM; Korir H; Riner DK; Ochanda H; Lee YM; Secor WE; Karanja DM; Colley DG
    Parasite Immunol; 2018 Jun; 40(6):e12530. PubMed ID: 29604074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.